Commerzbank Aktiengesellschaft Novo Nordisk A S Transaction History

Commerzbank Aktiengesellschaft

$3.75 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$49.46 - $64.78 $3.8 Million - $4.97 Million	-76,753 Closed	0 $0
Q4 2019 Oct 03, 2024	BUY	$49.86 - $58.26 $3.83 Million - $4.47 Million	76,753 New	76,753 $4.44 Million
Q4 2019 Jan 17, 2020	SELL	$49.86 - $58.26 $428,646 - $500,861	-8,597 Reduced 10.07%	76,753 $4.44 Million
Q3 2019 Oct 03, 2024	BUY	$47.54 - $53.43 $4.06 Million - $4.56 Million	85,350 New	85,350 $4.41 Million
Q2 2019 Oct 03, 2024	BUY	$46.79 - $52.47 $3.99 Million - $4.48 Million	85,350 New	85,350 $4.36 Million
Q2 2019 Jul 23, 2019	BUY	$46.79 - $52.47 $486,803 - $545,897	10,404 Added 13.88%	85,350 $4.36 Million
Q1 2019 Oct 03, 2024	BUY	$46.36 - $52.63 $3.47 Million - $3.94 Million	74,946 New	74,946 $3.92 Million
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $1.58 Million - $1.8 Million	-34,111 Reduced 31.28%	74,946 $3.92 Million
Q4 2018 Oct 03, 2024	BUY	$41.54 - $47.25 $4.48 Million - $5.1 Million	107,832 New	107,832 $4.97 Million
Q4 2018 Feb 06, 2019	BUY	$41.54 - $47.25 $54,126 - $61,566	1,303 Added 1.21%	109,057 $5.02 Million
Q3 2018 Oct 04, 2024	BUY	$46.76 - $51.24 $5.04 Million - $5.52 Million	107,754 New	107,754 $5.08 Million
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $200,974 - $220,229	-4,298 Reduced 3.84%	107,754 $5.08 Million
Q2 2018 Oct 04, 2024	BUY	$44.29 - $50.42 $4.96 Million - $5.65 Million	112,052 New	112,052 $5.17 Million
Q2 2018 Aug 10, 2018	BUY	$44.29 - $50.42 $72,724 - $82,789	1,642 Added 1.49%	112,052 $5.17 Million
Q1 2018 Oct 04, 2024	SELL	$48.49 - $58.14 $1.03 Million - $1.23 Million	-21,217 Reduced 16.12%	110,410 $5.44 Million
Q1 2018 May 01, 2018	SELL	$48.49 - $58.14 $1.03 Million - $1.23 Million	-21,217 Reduced 16.12%	110,410 $5.44 Million
Q4 2017 Oct 04, 2024	BUY	$47.53 - $53.73 $6.26 Million - $7.07 Million	131,627 New	131,627 $7.06 Million
Q4 2017 Jan 26, 2018	SELL	$47.53 - $53.73 $733,720 - $829,430	-15,437 Reduced 10.5%	131,627 $7.06 Million
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $1.53 Million - $1.83 Million	-37,102 Reduced 20.15%	147,064 $7.08 Million
Q2 2017 Aug 09, 2017	BUY	N/A	184,166	184,166 $7.9 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.77 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $198B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account